APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anticholinergic Agent

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Anticholinergic Agent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025196 pages

Choose your research edition.

Industry ResearchAnticholinergic Agent Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Anticholinergic Agent Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Anticholinergic Agent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anticholinergic Agent Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Anticholinergic Agent Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Anticholinergic Agent market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Anticholinergic Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Anticholinergic Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anticholinergic Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Anticholinergic Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Anticholinergic Agent include Astellas Pharma Inc, Aurobindo Pharma, Boehringer Ingelheim, GlaxoSmithKline, Macleods Pharmaceuticals, Novartis AG, Perrigo, Teva Pharmaceutical and AstraZeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Anticholinergic Agent market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Anticholinergic Agent and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Anticholinergic Agent sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Anticholinergic Agent market size, projected growth trends, production technologies, key applications, and end-use industries.

Anticholinergic Agent Segment by Company

Astellas Pharma Inc

Aurobindo Pharma

Boehringer Ingelheim

GlaxoSmithKline

Macleods Pharmaceuticals

Novartis AG

Perrigo

Teva Pharmaceutical

AstraZeneca

AbbVie

Hansoh Pharmaceutical

Hengrui

Pfizer

Joincare Pharmaceutical

Mylan

Sanofi

Sun Pharmaceutical

Anticholinergic Agent Segment by Type

Muscarinic Antagonists

Nicotinic Antagonists

Anticholinergic Agent Segment by Application

Chronic Obstructive Pulmonary Disease

Parkinson's Disease

Surgery

Asthma

Anticholinergic Agent Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anticholinergic Agent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anticholinergic Agent and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anticholinergic Agent.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Anticholinergic Agent market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Anticholinergic Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Anticholinergic Agent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Anticholinergic Agent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Anticholinergic Agent Industry Trends Table 2. Anticholinergic Agent Industry Drivers Table 3. Anticholinergic Agent Industry Opportunities and Challenges Table 4. Anticholinergic Agent Industry Restraints Table 5. Global Anticholinergic Agent Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Anticholinergic Agent Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Anticholinergic Agent Sales by Manufacturers (Kg) & (2021-2026) Table 8. Global Anticholinergic Agent Sales Market Share by Manufacturers Table 9. Global Anticholinergic Agent Average Sales Price (US$/g) of Manufacturers (2021-2026) Table 10. Global Anticholinergic Agent Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Anticholinergic Agent Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Anticholinergic Agent Manufacturers, Product Type & Application Table 13. Global Anticholinergic Agent Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Anticholinergic Agent by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Muscarinic Antagonists Table 17. Major Manufacturers of Nicotinic Antagonists Table 18. Global Anticholinergic Agent Sales by Type 2021 VS 2025 VS 2032 (Kg) Table 19. Global Anticholinergic Agent Sales by Type (2021-2026) & (Kg) Table 20. Global Anticholinergic Agent Sales by Type (2027-2032) & (Kg) Table 21. Global Anticholinergic Agent Sales Market Share by Type (2021-2026) Table 22. Global Anticholinergic Agent Sales Market Share by Type (2027-2032) Table 23. Global Anticholinergic Agent Revenue by Type 2021 VS 2025 VS 2032 (Kg) Table 24. Global Anticholinergic Agent Revenue by Type (2021-2026) & (Kg) Table 25. Global Anticholinergic Agent Revenue by Type (2027-2032) & (Kg) Table 26. Global Anticholinergic Agent Revenue Market Share by Type (2021-2026) Table 27. Global Anticholinergic Agent Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Chronic Obstructive Pulmonary Disease Table 29. Major Manufacturers of Parkinson's Disease Table 30. Major Manufacturers of Surgery Table 31. Major Manufacturers of Asthma Table 32. Global Anticholinergic Agent Sales by Application 2021 VS 2025 VS 2032 (Kg) Table 33. Global Anticholinergic Agent Sales by Application (2021-2026) & (Kg) Table 34. Global Anticholinergic Agent Sales by Application (2027-2032) & (Kg) Table 35. Global Anticholinergic Agent Sales Market Share by Application (2021-2026) Table 36. Global Anticholinergic Agent Sales Market Share by Application (2027-2032) Table 37. Global Anticholinergic Agent Revenue by Application 2021 VS 2025 VS 2032 (Kg) Table 38. Global Anticholinergic Agent Revenue by Application (2021-2026) & (Kg) Table 39. Global Anticholinergic Agent Revenue by Application (2027-2032) & (Kg) Table 40. Global Anticholinergic Agent Revenue Market Share by Application (2021-2026) Table 41. Global Anticholinergic Agent Revenue Market Share by Application (2027-2032) Table 42. Global Anticholinergic Agent Sales by Region: 2021 VS 2025 VS 2032 (Kg) Table 43. Global Anticholinergic Agent Sales by Region (2021-2026) & (Kg) Table 44. Global Anticholinergic Agent Sales Market Share by Region (2021-2026) Table 45. Global Anticholinergic Agent Sales Forecasted by Region (2027-2032) & (Kg) Table 46. Global Anticholinergic Agent Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Anticholinergic Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 48. North America Anticholinergic Agent Sales by Country (2021-2026) & (Kg) Table 49. North America Anticholinergic Agent Sales by Country (2027-2032) & (Kg) Table 50. Europe Anticholinergic Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 51. Europe Anticholinergic Agent Sales by Country (2021-2026) & (Kg) Table 52. Europe Anticholinergic Agent Sales by Country (2027-2032) & (Kg) Table 53. Asia Pacific Anticholinergic Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 54. Asia Pacific Anticholinergic Agent Sales by Country (2021-2026) & (Kg) Table 55. Asia Pacific Anticholinergic Agent Sales by Country (2027-2032) & (Kg) Table 56. South America, Middle East and Africa Anticholinergic Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 57. South America, Middle East and Africa Anticholinergic Agent Sales by Country (2021-2026) & (Kg) Table 58. South America, Middle East and Africa Anticholinergic Agent Sales by Country (2027-2032) & (Kg) Table 59. Global Anticholinergic Agent Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Anticholinergic Agent Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Anticholinergic Agent Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Anticholinergic Agent Revenue Market Share by Region (2021-2026) Table 63. Global Anticholinergic Agent Revenue Market Share by Region (2027-2032) Table 64. Astellas Pharma Inc Company Information Table 65. Astellas Pharma Inc Business Overview Table 66. Astellas Pharma Inc Anticholinergic Agent Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Astellas Pharma Inc Anticholinergic Agent Product Portfolio Table 68. Astellas Pharma Inc Recent Development Table 69. Aurobindo Pharma Company Information Table 70. Aurobindo Pharma Business Overview Table 71. Aurobindo Pharma Anticholinergic Agent Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Aurobindo Pharma Anticholinergic Agent Product Portfolio Table 73. Aurobindo Pharma Recent Development Table 74. Boehringer Ingelheim Company Information Table 75. Boehringer Ingelheim Business Overview Table 76. Boehringer Ingelheim Anticholinergic Agent Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Boehringer Ingelheim Anticholinergic Agent Product Portfolio Table 78. Boehringer Ingelheim Recent Development Table 79. GlaxoSmithKline Company Information Table 80. GlaxoSmithKline Business Overview Table 81. GlaxoSmithKline Anticholinergic Agent Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. GlaxoSmithKline Anticholinergic Agent Product Portfolio Table 83. GlaxoSmithKline Recent Development Table 84. Macleods Pharmaceuticals Company Information Table 85. Macleods Pharmaceuticals Business Overview Table 86. Macleods Pharmaceuticals Anticholinergic Agent Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Macleods Pharmaceuticals Anticholinergic Agent Product Portfolio Table 88. Macleods Pharmaceuticals Recent Development Table 89. Novartis AG Company Information Table 90. Novartis AG Business Overview Table 91. Novartis AG Anticholinergic Agent Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Novartis AG Anticholinergic Agent Product Portfolio Table 93. Novartis AG Recent Development Table 94. Perrigo Company Information Table 95. Perrigo Business Overview Table 96. Perrigo Anticholinergic Agent Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Perrigo Anticholinergic Agent Product Portfolio Table 98. Perrigo Recent Development Table 99. Teva Pharmaceutical Company Information Table 100. Teva Pharmaceutical Business Overview Table 101. Teva Pharmaceutical Anticholinergic Agent Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Teva Pharmaceutical Anticholinergic Agent Product Portfolio Table 103. Teva Pharmaceutical Recent Development Table 104. AstraZeneca Company Information Table 105. AstraZeneca Business Overview Table 106. AstraZeneca Anticholinergic Agent Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. AstraZeneca Anticholinergic Agent Product Portfolio Table 108. AstraZeneca Recent Development Table 109. AbbVie Company Information Table 110. AbbVie Business Overview Table 111. AbbVie Anticholinergic Agent Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. AbbVie Anticholinergic Agent Product Portfolio Table 113. AbbVie Recent Development Table 114. Hansoh Pharmaceutical Company Information Table 115. Hansoh Pharmaceutical Business Overview Table 116. Hansoh Pharmaceutical Anticholinergic Agent Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Hansoh Pharmaceutical Anticholinergic Agent Product Portfolio Table 118. Hansoh Pharmaceutical Recent Development Table 119. Hengrui Company Information Table 120. Hengrui Business Overview Table 121. Hengrui Anticholinergic Agent Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Hengrui Anticholinergic Agent Product Portfolio Table 123. Hengrui Recent Development Table 124. Pfizer Company Information Table 125. Pfizer Business Overview Table 126. Pfizer Anticholinergic Agent Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Pfizer Anticholinergic Agent Product Portfolio Table 128. Pfizer Recent Development Table 129. Joincare Pharmaceutical Company Information Table 130. Joincare Pharmaceutical Business Overview Table 131. Joincare Pharmaceutical Anticholinergic Agent Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Joincare Pharmaceutical Anticholinergic Agent Product Portfolio Table 133. Joincare Pharmaceutical Recent Development Table 134. Mylan Company Information Table 135. Mylan Business Overview Table 136. Mylan Anticholinergic Agent Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Mylan Anticholinergic Agent Product Portfolio Table 138. Mylan Recent Development Table 139. Sanofi Company Information Table 140. Sanofi Business Overview Table 141. Sanofi Anticholinergic Agent Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. Sanofi Anticholinergic Agent Product Portfolio Table 143. Sanofi Recent Development Table 144. Sun Pharmaceutical Company Information Table 145. Sun Pharmaceutical Business Overview Table 146. Sun Pharmaceutical Anticholinergic Agent Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 147. Sun Pharmaceutical Anticholinergic Agent Product Portfolio Table 148. Sun Pharmaceutical Recent Development Table 149. Key Raw Materials Table 150. Raw Materials Key Suppliers Table 151. Anticholinergic Agent Distributors List Table 152. Anticholinergic Agent Customers List Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources Table 156. Primary Sources List of Figures Figure 1. Anticholinergic Agent Product Image Figure 2. Global Anticholinergic Agent Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anticholinergic Agent Market Size (2021-2032) & (US$ Million) Figure 4. Global Anticholinergic Agent Sales (2021-2032) & (Kg) Figure 5. Global Anticholinergic Agent Average Price (US$/g) & (2021-2032) Figure 6. Global Top 5 and 10 Anticholinergic Agent Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Muscarinic Antagonists Image Figure 9. Nicotinic Antagonists Image Figure 10. Global Anticholinergic Agent Sales by Type (2021 VS 2025 VS 2032) & (Kg) Figure 11. Global Anticholinergic Agent Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Anticholinergic Agent Sales Market Share by Type (2021-2032) Figure 13. Global Anticholinergic Agent Revenue by Type (2021 VS 2025 VS 2032) & (Kg) Figure 14. Global Anticholinergic Agent Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Anticholinergic Agent Revenue Market Share by Type (2021-2032) Figure 16. Chronic Obstructive Pulmonary Disease Image Figure 17. Parkinson's Disease Image Figure 18. Surgery Image Figure 19. Asthma Image Figure 20. Global Anticholinergic Agent Sales by Application (2021 VS 2025 VS 2032) & (Kg) Figure 21. Global Anticholinergic Agent Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Anticholinergic Agent Sales Market Share by Application (2021-2032) Figure 23. Global Anticholinergic Agent Revenue by Application (2021 VS 2025 VS 2032) & (Kg) Figure 24. Global Anticholinergic Agent Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Anticholinergic Agent Revenue Market Share by Application (2021-2032) Figure 26. North America Anticholinergic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 27. North America Anticholinergic Agent Sales Market Share by Country (2021-2032) Figure 28. U.S. Anticholinergic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 29. Canada Anticholinergic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 30. Mexico Anticholinergic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 31. Europe Anticholinergic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 32. Europe Anticholinergic Agent Sales Market Share by Country (2021-2032) Figure 33. Germany Anticholinergic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 34. France Anticholinergic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 35. U.K. Anticholinergic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 36. Italy Anticholinergic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 37. Netherlands Anticholinergic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 38. Asia Pacific Anticholinergic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 39. Asia Pacific Anticholinergic Agent Sales Market Share by Country (2021-2032) Figure 40. China Anticholinergic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 41. Japan Anticholinergic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 42. South Korea Anticholinergic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 43. Southeast Asia Anticholinergic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 44. India Anticholinergic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 45. Australia Anticholinergic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 46. South America, Middle East and Africa Anticholinergic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 47. South America, Middle East and Africa Anticholinergic Agent Sales Market Share by Country (2021-2032) Figure 48. Brazil Anticholinergic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 49. South Africa Anticholinergic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 50. Saudi Arabia Anticholinergic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 51. Turkey Anticholinergic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 52. Argentina Anticholinergic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 53. UAE Anticholinergic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 54. Egypt Anticholinergic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 55. Chile Anticholinergic Agent Sales and Growth Rate (2021-2032) & (Kg) Figure 56. Global Anticholinergic Agent Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Anticholinergic Agent Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Anticholinergic Agent Revenue (2021-2032) & (US$ Million) Figure 59. North America Anticholinergic Agent Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Anticholinergic Agent Revenue (2021-2032) & (US$ Million) Figure 61. Europe Anticholinergic Agent Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Anticholinergic Agent Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Anticholinergic Agent Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Anticholinergic Agent Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Anticholinergic Agent Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Anticholinergic Agent Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Anticholinergic Agent Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Muscarinic Antagonists
  • Nicotinic Antagonists
Applications
  • Chronic Obstructive Pulmonary Disease
  • Parkinson's Disease
  • Surgery
  • Asthma
Companies covered
  • Astellas Pharma Inc
  • Aurobindo Pharma
  • Boehringer Ingelheim
  • GlaxoSmithKline
  • Macleods Pharmaceuticals
  • Novartis AG
  • Perrigo
  • Teva Pharmaceutical
  • AstraZeneca
  • AbbVie
  • Hansoh Pharmaceutical
  • Hengrui
  • Pfizer
  • Joincare Pharmaceutical
  • Mylan
  • Sanofi
  • Sun Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Anticholinergic Agent Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Anticholinergic Agent Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Anticholinergic Agent Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Anticholinergic Agent Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Anticholinergic Agent Market Dynamics
  1. 2.1 Anticholinergic Agent Industry Trends
  2. 2.2 Anticholinergic Agent Industry Drivers
  3. 2.3 Anticholinergic Agent Industry Opportunities and Challenges
  4. 2.4 Anticholinergic Agent Industry Restraints
3 Anticholinergic Agent Market by Manufacturers
  1. 3.1 Global Anticholinergic Agent Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Anticholinergic Agent Sales by Manufacturers (2021-2026)
  3. 3.3 Global Anticholinergic Agent Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Anticholinergic Agent Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Anticholinergic Agent Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Anticholinergic Agent Manufacturers, Product Type & Application
  7. 3.7 Global Anticholinergic Agent Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Anticholinergic Agent Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Anticholinergic Agent Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Anticholinergic Agent Tier 1, Tier 2, and Tier 3
4 Anticholinergic Agent Market by Type
  1. 4.1 Anticholinergic Agent Type Introduction
  2. 4.1.1 Muscarinic Antagonists
  3. 4.1.2 Nicotinic Antagonists
  4. 4.2 Global Anticholinergic Agent Sales by Type
  5. 4.2.1 Global Anticholinergic Agent Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Anticholinergic Agent Sales by Type (2021-2032)
  7. 4.2.3 Global Anticholinergic Agent Sales Market Share by Type (2021-2032)
  8. 4.3 Global Anticholinergic Agent Revenue by Type
  9. 4.3.1 Global Anticholinergic Agent Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Anticholinergic Agent Revenue by Type (2021-2032)
  11. 4.3.3 Global Anticholinergic Agent Revenue Market Share by Type (2021-2032)
5 Anticholinergic Agent Market by Application
  1. 5.1 Anticholinergic Agent Application Introduction
  2. 5.1.1 Chronic Obstructive Pulmonary Disease
  3. 5.1.2 Parkinson's Disease
  4. 5.1.3 Surgery
  5. 5.1.4 Asthma
  6. 5.2 Global Anticholinergic Agent Sales by Application
  7. 5.2.1 Global Anticholinergic Agent Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Anticholinergic Agent Sales by Application (2021-2032)
  9. 5.2.3 Global Anticholinergic Agent Sales Market Share by Application (2021-2032)
  10. 5.3 Global Anticholinergic Agent Revenue by Application
  11. 5.3.1 Global Anticholinergic Agent Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Anticholinergic Agent Revenue by Application (2021-2032)
  13. 5.3.3 Global Anticholinergic Agent Revenue Market Share by Application (2021-2032)
6 Global Anticholinergic Agent Sales by Region
  1. 6.1 Global Anticholinergic Agent Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Anticholinergic Agent Sales by Region (2021-2032)
  3. 6.2.1 Global Anticholinergic Agent Sales by Region (2021-2026)
  4. 6.2.2 Global Anticholinergic Agent Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Anticholinergic Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Anticholinergic Agent Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Anticholinergic Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Anticholinergic Agent Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Anticholinergic Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Anticholinergic Agent Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Anticholinergic Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Anticholinergic Agent Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Anticholinergic Agent Revenue by Region
  1. 7.1 Global Anticholinergic Agent Revenue by Region
  2. 7.1.1 Global Anticholinergic Agent Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Anticholinergic Agent Revenue by Region (2021-2026)
  4. 7.1.3 Global Anticholinergic Agent Revenue by Region (2027-2032)
  5. 7.1.4 Global Anticholinergic Agent Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Anticholinergic Agent Revenue (2021-2032)
  8. 7.2.2 North America Anticholinergic Agent Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Anticholinergic Agent Revenue (2021-2032)
  11. 7.3.2 Europe Anticholinergic Agent Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Anticholinergic Agent Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Anticholinergic Agent Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Anticholinergic Agent Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Anticholinergic Agent Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Astellas Pharma Inc
  2. 8.1.1 Astellas Pharma Inc Company Information
  3. 8.1.2 Astellas Pharma Inc Business Overview
  4. 8.1.3 Astellas Pharma Inc Anticholinergic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Astellas Pharma Inc Anticholinergic Agent Product Portfolio
  6. 8.1.5 Astellas Pharma Inc Recent Developments
  7. 8.2 Aurobindo Pharma
  8. 8.2.1 Aurobindo Pharma Company Information
  9. 8.2.2 Aurobindo Pharma Business Overview
  10. 8.2.3 Aurobindo Pharma Anticholinergic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Aurobindo Pharma Anticholinergic Agent Product Portfolio
  12. 8.2.5 Aurobindo Pharma Recent Developments
  13. 8.3 Boehringer Ingelheim
  14. 8.3.1 Boehringer Ingelheim Company Information
  15. 8.3.2 Boehringer Ingelheim Business Overview
  16. 8.3.3 Boehringer Ingelheim Anticholinergic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Boehringer Ingelheim Anticholinergic Agent Product Portfolio
  18. 8.3.5 Boehringer Ingelheim Recent Developments
  19. 8.4 GlaxoSmithKline
  20. 8.4.1 GlaxoSmithKline Company Information
  21. 8.4.2 GlaxoSmithKline Business Overview
  22. 8.4.3 GlaxoSmithKline Anticholinergic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 GlaxoSmithKline Anticholinergic Agent Product Portfolio
  24. 8.4.5 GlaxoSmithKline Recent Developments
  25. 8.5 Macleods Pharmaceuticals
  26. 8.5.1 Macleods Pharmaceuticals Company Information
  27. 8.5.2 Macleods Pharmaceuticals Business Overview
  28. 8.5.3 Macleods Pharmaceuticals Anticholinergic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Macleods Pharmaceuticals Anticholinergic Agent Product Portfolio
  30. 8.5.5 Macleods Pharmaceuticals Recent Developments
  31. 8.6 Novartis AG
  32. 8.6.1 Novartis AG Company Information
  33. 8.6.2 Novartis AG Business Overview
  34. 8.6.3 Novartis AG Anticholinergic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Novartis AG Anticholinergic Agent Product Portfolio
  36. 8.6.5 Novartis AG Recent Developments
  37. 8.7 Perrigo
  38. 8.7.1 Perrigo Company Information
  39. 8.7.2 Perrigo Business Overview
  40. 8.7.3 Perrigo Anticholinergic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Perrigo Anticholinergic Agent Product Portfolio
  42. 8.7.5 Perrigo Recent Developments
  43. 8.8 Teva Pharmaceutical
  44. 8.8.1 Teva Pharmaceutical Company Information
  45. 8.8.2 Teva Pharmaceutical Business Overview
  46. 8.8.3 Teva Pharmaceutical Anticholinergic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Teva Pharmaceutical Anticholinergic Agent Product Portfolio
  48. 8.8.5 Teva Pharmaceutical Recent Developments
  49. 8.9 AstraZeneca
  50. 8.9.1 AstraZeneca Company Information
  51. 8.9.2 AstraZeneca Business Overview
  52. 8.9.3 AstraZeneca Anticholinergic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 AstraZeneca Anticholinergic Agent Product Portfolio
  54. 8.9.5 AstraZeneca Recent Developments
  55. 8.10 AbbVie
  56. 8.10.1 AbbVie Company Information
  57. 8.10.2 AbbVie Business Overview
  58. 8.10.3 AbbVie Anticholinergic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 AbbVie Anticholinergic Agent Product Portfolio
  60. 8.10.5 AbbVie Recent Developments
  61. 8.11 Hansoh Pharmaceutical
  62. 8.11.1 Hansoh Pharmaceutical Company Information
  63. 8.11.2 Hansoh Pharmaceutical Business Overview
  64. 8.11.3 Hansoh Pharmaceutical Anticholinergic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Hansoh Pharmaceutical Anticholinergic Agent Product Portfolio
  66. 8.11.5 Hansoh Pharmaceutical Recent Developments
  67. 8.12 Hengrui
  68. 8.12.1 Hengrui Company Information
  69. 8.12.2 Hengrui Business Overview
  70. 8.12.3 Hengrui Anticholinergic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Hengrui Anticholinergic Agent Product Portfolio
  72. 8.12.5 Hengrui Recent Developments
  73. 8.13 Pfizer
  74. 8.13.1 Pfizer Company Information
  75. 8.13.2 Pfizer Business Overview
  76. 8.13.3 Pfizer Anticholinergic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Pfizer Anticholinergic Agent Product Portfolio
  78. 8.13.5 Pfizer Recent Developments
  79. 8.14 Joincare Pharmaceutical
  80. 8.14.1 Joincare Pharmaceutical Company Information
  81. 8.14.2 Joincare Pharmaceutical Business Overview
  82. 8.14.3 Joincare Pharmaceutical Anticholinergic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Joincare Pharmaceutical Anticholinergic Agent Product Portfolio
  84. 8.14.5 Joincare Pharmaceutical Recent Developments
  85. 8.15 Mylan
  86. 8.15.1 Mylan Company Information
  87. 8.15.2 Mylan Business Overview
  88. 8.15.3 Mylan Anticholinergic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Mylan Anticholinergic Agent Product Portfolio
  90. 8.15.5 Mylan Recent Developments
  91. 8.16 Sanofi
  92. 8.16.1 Sanofi Company Information
  93. 8.16.2 Sanofi Business Overview
  94. 8.16.3 Sanofi Anticholinergic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Sanofi Anticholinergic Agent Product Portfolio
  96. 8.16.5 Sanofi Recent Developments
  97. 8.17 Sun Pharmaceutical
  98. 8.17.1 Sun Pharmaceutical Company Information
  99. 8.17.2 Sun Pharmaceutical Business Overview
  100. 8.17.3 Sun Pharmaceutical Anticholinergic Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Sun Pharmaceutical Anticholinergic Agent Product Portfolio
  102. 8.17.5 Sun Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Anticholinergic Agent Value Chain Analysis
  2. 9.1.1 Anticholinergic Agent Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Anticholinergic Agent Production Mode & Process
  6. 9.2 Anticholinergic Agent Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Anticholinergic Agent Distributors
  9. 9.2.3 Anticholinergic Agent Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst